Manufacturer:
Misc
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
reduction of serum phosphorus in patients with end stage renal disease
Conditions:
- Hyperphosphatemia
- Chronic Kidney Disease
Therapeutic Area:
- Endocrinology
- Nephrology